AI and computational design at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
28 organizations at Antibody Engineering 2026 present work in AI & computational design: 17 suppliers and service providers, 6 drug developers and 5 academic, government and non-profit bodies. Between them they bring 29 presentations to the program. Most represented: Amgen (3 on the program), Twist Bioscience (2 on the program), Nona Biosciences (2 on the program). As of Nov 10, 2026.
Format
Top represented
Showing 1–15 of 28 organizations
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Amgen Thousand Oaks, CA | |
Global biopharmaceutical company developing and manufacturing biologic medicines, including bispecific T-cell engagers. | Chair Sun Dec 13 1:00pm–1:15pm Talk Sun Dec 13 1:15pm–1:45pm Developability-Guided Generative Biology for Therapeutic Protein Engineering Designing new therapeutic proteins by computer while checking from the start that they can be made and purified. AI & computational design Talk Sun Dec 13 4:15pm–5:00pm Talk Mon Dec 14 5:45pm–6:15pm Induced Proximity and Next-Generation Antibody Therapeutics Bispecifics & multispecifics |
Twist Bioscience South San Francisco, CA | |
Synthetic DNA company whose biopharma unit provides antibody libraries and antibody discovery and optimization services. | Booth Exhibiting at Booth 200 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 12:15pm–1:15pm Scaling Wet-Lab Validation for AI-based Biologic Discovery Why lab testing has become the bottleneck for AI antibody design, and how a shared model platform from Eli Lilly connects to it. AI & computational designAntibody discovery Talk Tue Dec 15 1:40pm–2:00pm Screening in the Format You’ll Develop In: Cell-Free Expression of Full-Length IgG Making full-length antibodies without cells at screening scale, and how their binding compares with the same antibodies made in mammalian cells. Antibody discovery Talk Wed Dec 16 7:30am–8:00am Engineering for Better Bispecifics: Introducing the B-Body® Platform A two-target antibody design meant to assemble reliably, avoiding low yields and hard purification when production scales up. Bispecifics & multispecificsDevelopability & CMC |
Fully human antibody discovery built on its Harbour Mice transgenic platforms for conventional and heavy-chain-only antibodies, offered as integrated discovery services. | Booth Exhibiting at Booth 203 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 1:45pm–2:15pm A Fully Human, AI-native Discovery and Development Platform for Next-generation Modality Solutions How fully human antibody mice combined with AI design feed immune cell engagers, brain-crossing antibodies, drug conjugates and other complex formats. Antibody discoveryAI & computational design Talk Tue Dec 15 11:30am–12:00pm VHH to Mice – With a Focus on In vivo Discovery/Screening Approaches for Therapeutic Discovery Applications Why single-domain human antibodies from engineered mice suit CAR-T cells and T-cell engagers, and how testing for target-cell killing picks better candidates. Bispecifics & multispecifics |
University of Texas at Austin Austin, TX | |
Public research university in Austin, Texas. | Talk Mon Dec 14 5:15pm–5:45pm Computational Approaches for Antibody and TCR Modeling Design and Discovery AI & computational design Talk Tue Dec 15 10:30am–11:00am |
A-Alpha Bio Seattle, WA | |
Measures protein-protein binding at scale with its AlphaSeq platform and uses the data to train models for antibody optimization with partners. | Booth Exhibiting at Booth 405 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Tue Dec 15 12:35pm–1:05pm Predictive Multi-Objective Antibody Optimization Powered by Millions of Quantitative Affinity Measurements A model trained on millions of binding-strength measurements that predicts how far an antibody can be mutated and still bind. AI & computational designProtein engineering |
Asimov Boston, MA | |
Offers CHO cell line development services built on its CHO Edge expression system and genetic design software for biologics manufacturing. | Booth Exhibiting at Booth 101 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 1:45pm–2:15pm An AI-Driven Approach to CHO Biologics Production How a platform combining AI and synthetic biology builds high-yield Chinese hamster ovary cell lines for antibodies, including bispecific and multispecific ones. Developability & CMCAI & computational design |
Provides recombinant antibody expression and production services, plus antibody discovery, for drug developers. | Booth Exhibiting at Booth 212 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Tue Dec 15 12:05pm–12:35pm Wet-lab data acquisition for rapid iteration of AI-powered macromolecular drugs Standardized lab data delivered in days, so the AI models designing millions of antibody candidates can be retrained more quickly. AI & computational design |
Cradle Amsterdam, Netherlands | |
AI software for protein engineering that suggests improved antibody and protein sequences from lab data. | Booth Exhibiting (no floor booth listed) Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Tue Dec 15 12:35pm–1:05pm Generative AI for End-to-End Biologics Engineering: Scalable, Robust and Lab-Validated How generative AI is applied across antibody and protein engineering, from first designs to optimizing several properties, with lab testing feeding the models. AI & computational designProtein engineering |
Formerly ImmunoPrecise Antibodies; combines AI data tools such as LensAI and ReefIQ with wet-lab antibody discovery. | Booth Exhibiting at Booth 312 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 1:15pm–1:45pm From Fragmented Data to Reasoning Infrastructure: How ReefIQ and LensAI Turn Antibody Discovery Data Into Governed, Computable Biology Linking scattered antibody sequence, structure and assay records so software can reason over them instead of rebuilding the links. AI & computational design |
BigHat Biosciences San Mateo, CA | |
Designs antibody therapeutics with machine learning and a high-throughput wet lab; runs its own pipeline and pharma partnerships. | Talk Tue Dec 15 5:15pm–5:45pm Machine Learning Guided Design of Avidity- and Logic-Gated T Cell Engagers Using machine learning to tune binding strength so T-cell-recruiting antibodies act on diseased cells and spare healthy ones. AI & computational design |
Divergence Labs New York, NY | |
Drug developer combining computational models and lab work to discover medicines, with ophthalmology programs in its pipeline. | Talk Mon Dec 14 3:00pm–3:30pm One-Shot Antibody Design with AI: Are We There Yet? An assessment of how much of computer-designed antibody discovery really works today, and what still does not. AI & computational design |
Eli Lilly Indianapolis, IN | |
Global pharmaceutical company whose TuneLab platform offers biotech companies AI models trained on Lilly research data. | Talk Mon Dec 14 12:15pm–1:15pm Scaling Wet-Lab Validation for AI-based Biologic Discovery Why lab testing has become the bottleneck for AI antibody design, and how a shared model platform from Eli Lilly connects to it. AI & computational designAntibody discovery |
EMD Serono Rockland, MA | |
US and Canadian healthcare business of Merck KGaA, Darmstadt, developing medicines in oncology, neurology and fertility. | Talk Sun Dec 13 1:45pm–2:15pm A Combined Computational and Experimental Cascade for Variable Domain Assessment and Optimization Towards Developable Multispecific Antibodies Splitting a multi-target antibody into its binding pieces and improving each one without losing target binding. AI & computational design |
EpiVax Providence, RI | |
Offers in silico immunogenicity screening tools and matching human immune assays for antibody and protein therapeutics. | Panel Sun Dec 13 4:15pm–4:45pm Beyond Sequence Prediction: Integrating AI-Driven In Silico Analysis with Human Immune Assays for Antibody Engineering Combining predictions of immune reactions against a drug with tests on human blood cells to design safer antibodies. AI & computational design |
Icahn School of Medicine at Mount Sinai New York, NY | |
Medical school of the Mount Sinai Health System in New York. | Talk Wed Dec 16 8:45am–9:15am From Nanobody Repertoires to Programmable Medicines: Proteomics, AF3-TurboAb, and Multivalent Design Designing small single-domain antibodies using computer models of how they grip their targets, aimed at infections, toxins and cancer. AI & computational design |
Find buyers in AI & computational design
Tell us what you sell and we’ll find the people at organizations working on AI & computational design most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse Antibody Engineering 2026 by
Organization type
Topic
Exhibit hall
Everyone
Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction